びまん性大細胞型B細胞リンパ腫患者における線量低減地固め放射線療法

基本情報

NCT ID: NCT03681535
ステータス: 実施中（募集終了）
試験のフェーズ: 該当なし
試験タイプ: 介入
目標被験者数: 241
治験依頼者名: Duke University

概要

This phase II study will evaluate whether a reduction in radiation dose and field size will maintain a high rate of local control while minimizing the risk of acute and late toxicity . Hypothesis: The radiation dose and treatment volume can be safely reduced from 30 Gy to 20 Gy while maintaining high rates of local control in patients who had a negative PET-CT scan following rituximab - containing chemotherapy.

対象疾患

Diffuse Large B Cell Lymphoma

介入

Radiation Therapy(RADIATION)

依頼者（Sponsor）

Duke University(OTHER)

実施施設 (2)

Juntendo University

Tokyo, Japan

Juntendo University

Tokyo, Japan